OREANDA-NEWS. GfK will bring together experts from its pricing, market access strategy and real-world evidence teams at the ISPOR 17th Annual European Congress, which is being held on 8-12 November in Amsterdam, the Netherlands.

In keeping with the theme of this year's ISPOR, "New challenges for improving European health care", GfK will be delivering a short course on “Reimbursement systems for pharmaceuticals in Europe”, as well as sessions on areas as diverse as "The NICE medical technologies evaluation program" and "Provincial entry of new drugs in China".

In addition, GfK specialists will be available at the company stand to discuss how they are supporting clients to progress from insight to evidence and from evidence to action.

David Mackenzie, GfK's industry lead for health, comments, “ISPOR represents the perfect opportunity to present Disease Atlas, which brings in-depth, integrated analysis of current clinical practice at the specialist level, plus an understanding of alignment and disconnects among physician, patient and payers. When combined with our expertise in payer insight and market access strategy, it creates a powerful platform for our healthcare clients”.